596 related articles for article (PubMed ID: 16499257)
21. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
LoBue PA; Moser KS
Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
[TBL] [Abstract][Full Text] [Related]
23. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
[TBL] [Abstract][Full Text] [Related]
26. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
27. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
28. The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey.
Ozturk CE; Balbay OA; Kaya D; Ceyhan I; Bulut I; Sahin I
Jpn J Infect Dis; 2005 Feb; 58(1):47-9. PubMed ID: 15728994
[TBL] [Abstract][Full Text] [Related]
29. Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh.
Storla DG; Rahim Z; Islam MA; Plettner S; Begum V; Myrvang B; Bjune G; Rønnild E; Dahle UR; Mannsåker T
Scand J Infect Dis; 2007; 39(2):142-5. PubMed ID: 17366031
[TBL] [Abstract][Full Text] [Related]
30. Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002.
Tuberculosis Research Committee (Ryoken)
Int J Tuberc Lung Dis; 2007 Oct; 11(10):1129-35. PubMed ID: 17945071
[TBL] [Abstract][Full Text] [Related]
31. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
[TBL] [Abstract][Full Text] [Related]
32. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
33. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Bai GH; Park YK; Choi YW; Bai JI; Kim HJ; Chang CL; Lee JK; Kim SJ
Int J Tuberc Lung Dis; 2007 May; 11(5):571-6. PubMed ID: 17439684
[TBL] [Abstract][Full Text] [Related]
34. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
Abate G; Miörner H; Ahmed O; Hoffner SE
Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
36. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
37. Drug-resistant tuberculosis in Yangon, Myanmar.
Phyu S; Lwin T; Ti T; Maung W; Mar WW; Shein SS; Grewal HM
Scand J Infect Dis; 2005; 37(11-12):846-51. PubMed ID: 16308219
[TBL] [Abstract][Full Text] [Related]
38. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens.
Van Deun A; Aung KJ; Chowdhury S; Saha S; Pankaj A; Ashraf A; Rigouts L; Fissette K; Portaels F
Int J Tuberc Lung Dis; 1999 Feb; 3(2):143-8. PubMed ID: 10091880
[TBL] [Abstract][Full Text] [Related]
39. Drug-resistant tuberculosis in Budapest.
Fodor T; Vadász I; Lõrinczi I
Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
[TBL] [Abstract][Full Text] [Related]
40. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
